Overview

BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries. BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.

Sources

Funding

Core Team

• 

  Oguzhan Atay

  CEO & Co-Founder | 2016-01-01

• 

  Ross Taylor

  CFO | 2024-01-01

• 

  David Tsao

  Co-Founder & CTO | 2017-04-01

• 

  Shan Riku

  CPO | 2023-01-01

• 

  Jeff Hull

  Staff Software Engineer | 2021-04-01

Events

Opening

Jobs

Clinical Laboratory Associate (CLA)

2024-08-15

Union City, CA

Senior Scientist

2024-08-15

Menlo Park, CA

Senior Manager, Software Engineering, Oncology

2024-08-15

Menlo Park, CA

Senior Process Engineer

2024-08-15

Menlo Park, CA

Senior Bioinformatics Scientist

2024-08-15

Menlo Park, CA

Director, Product Marketing

2024-08-15

Menlo Park, CA

Senior Oncology Specialist

2024-08-15

United States

Senior Prenatal Specialist

2024-08-15

United States

Prenatal Account Manager

2024-08-15

United States

Tech Stack

• IPhone / Mobile Compatible

  mobile

• Viewport Meta

  mobile

• SPF

  mx

• SSL by Default

  ssl

• Google Tag Manager

  widgets

• Apple Mobile Web Clips Icon

  mobile

• Google Analytics

  analytics

• WordPress

  cms

• Content Delivery Network

  cdn

• Global Site Tag

  analytics

FAQ of BillionToOne

Coming soon